Billionaire Griffin Sold Amazon, Bets on Healthcare Giant
When top investors recalibrate, markets watch closely. This piece unpacks why the billionaire Griffin sold Amazon and...
Timing a rebalance for blue chip crypto holdings relies on predefined thresholds and market conditions. Use objective signals to keep allocation aligned with goals.
13,373 articlesWhen top investors recalibrate, markets watch closely. This piece unpacks why the billionaire Griffin sold Amazon and...
A once-in-a-century pattern is popping up in 2026. The stock market doing something unusual has historical precedents...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
Choosing between SPDR REIT ETF and Vanguard Global ex-U.S. Real Estate ETF? This practical guide explains how each fu...
Wall Street just wrapped a scorching quarter, leaving many investors dazzled by gains and wary of the risk. This guid...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Geopolitics shape energy markets, and a possible end to the Iran war could shift risks and returns for energy ETFs. T...
Insider selling often triggers headlines, but it isn’t a crystal ball for stock moves. This guide shows how to evalua...
Wall Street leaned on a familiar Fed playbook for years. Now a surprising pivot in that script could rattle stocks an...
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
Is it time to broaden your exposure beyond the U.S.? This guide breaks down why international ETFs can fit into a 202...
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...